The risk of developing a hepatocellular carcinoma from NAFLD can be assessed using the Polygenic Risk Score-5, which combines PNPLA3, TM6SF2, GCKR, and MBOAT7 [184]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.